Romancik, Jason T.
Cohen, Jonathon B.
Article History
Accepted: 28 May 2021
First Online: 23 November 2021
Declarations
:
: Jason T. Romancik declares that he has no conflict of interest.Jonathon B. Cohen receives research funding through grants from Takeda, Novartis, AstraZeneca, LAM Pharmaceuticals, Loxo Oncology, Bristol-Myers Squibb/Celgene, Genentech, and Bioinvent; and has received consulting fees from AstraZeneca, BeiGene, Aptitude Health, Adaptive Biotechnologies, AstraZeneca, Kite/Gilead, Adicet Bio, Janssen, and Pharmacyclics.